Company Registration No. 11211585 (England and Wales)
Aminoa Biostimulants Limited
Unaudited accounts
for the year ended 31 December 2024
Aminoa Biostimulants Limited
Unaudited accounts
Contents
Aminoa Biostimulants Limited
Company Information
for the year ended 31 December 2024
Directors
Mrs Judith Phillips
Mr Richard Phillips
Company Number
11211585 (England and Wales)
Registered Office
Nant Yr Ochain
Michaelston Y Fedw
Cardiff
CF3 6XT
Accountants
Evans Entwistle
Venta House
Maes-glas
Newport
NP20 2NS
Chartered Management Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of
Aminoa Biostimulants Limited
for the year ended 31 December 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Aminoa Biostimulants Limited for the year ended 31 December 2024 which comprise of the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.
As a CIMA Registered Member in Practice and Practising Certificate holder, I am subject to its ethical and other professional requirements which are detailed at https://www.cimaglobal.com/Members/Your-Membership-Information/Members-handbook/Licensing-and-monitoring/Members-in-practice/
Our work has been undertaken in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at http://www.cimaglobal.com.
Evans Entwistle
Member in Practice
Venta House
Maes-glas
Newport
NP20 2NS
18 September 2024
Aminoa Biostimulants Limited
Statement of financial position
as at 31 December 2024
Tangible assets
5,199
8,376
Cash at bank and in hand
8,369
27,995
Creditors: amounts falling due within one year
(4,281)
(8,620)
Net current assets
111,597
101,691
Total assets less current liabilities
116,796
110,067
Creditors: amounts falling due after more than one year
(11,586)
(15,831)
Provisions for liabilities
Called up share capital
1
1
Profit and loss account
104,221
92,644
Shareholders' funds
104,222
92,645
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 18 September 2025 and were signed on its behalf by
Mrs Judith Phillips
Director
Company Registration No. 11211585
Aminoa Biostimulants Limited
Notes to the Accounts
for the year ended 31 December 2024
Aminoa Biostimulants Limited is a private company, limited by shares, registered in England and Wales, registration number 11211585. The registered office is Nant Yr Ochain, Michaelston Y Fedw, Cardiff, CF3 6XT.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
5 years - straight line
Fixtures & fittings
5 years - straight line
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Expenditure on research and development is written off in the year in which it is incurred.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Aminoa Biostimulants Limited
Notes to the Accounts
for the year ended 31 December 2024
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
4
Tangible fixed assets
Total
At 31 December 2024
16,350
At 31 December 2024
11,151
5
Deferred taxation
2024
2023
Accelerated capital allowances
988
1,591
Provision at start of year
1,591
2,196
Credited to the profit and loss account
(603)
(605)
Provision at end of year
988
1,591
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1
1
7
Transactions with related parties
The company is connected to Aminoa Ltd (08908031), another company under common control. At the end of the year the company was due £14,817 (2023: £14,817) from Aminoa Ltd.
8
Average number of employees
During the year the average number of employees was 0 (2023: 0).